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SARS-CoV-2/novel coronavirus is a fresh virus strain that was first detected in the city of Wuhan located at Hubei province 
of China in December, 2019. Within a couple of months the virus has spread rapidly to different geographical regions 
through human transmission leading to serious disease burden worldwide. Although research is under progress to develop 
effective vaccine and drugs for the disease, a unified approach between conventional and traditional medicine system may 
prove to be beneficial in early prevention and management of the disease. Joint efforts are being put up at global scientific 
community level to enhance the research on advancement of meticulous diagnostics, antiviral measures and finally leading 
to development of an effective vaccine against the novel coronavirus. Some basic and safe measures from AYUSH systems 
of medicine have also been advocated for prophylaxis and treatment of COVID-19 which can be used independently or with 
integrated approach. The rationale of this review paper is to provide the details regarding disease spectrum, modes of 
transmission, social & economic consequences, and role of AYUSH systems of medicine in prevention and management of 
COVID-19. Based on the signs and symptoms of COVID-19, list of herbs and drugs of AYUSH systems of medicine were 
also searched and are being reported here. 
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There has always been threat of tackling emerging 
infections because of arrival of new viral infections or 
reoccurrence of viral infections, may be due to 
increasing population, poverty, malnutrition, environmental 
and global changes, misuse of antibiotics or prolonged 
usage of immunosuppressant agents, or surge in drug 
resistant microbes. An emerging infection is an 
infection that has either recently occurred in a general 
population or had existed before, but its incidence is 
on the rise on a faster pace. The recent outbreak of 
coronavirus infection has startled medical field.  
The novel corona virus (SARS-CoV-2) which caused 
the Coronavirus disease 2019 (COVID-19) pandemic 
was first found in Wuhan, China on December 31, 
2019
(ref. 1)
. WHO stressed on the dire need to make 
global endeavors for diagnosing and better 
comprehending COVID-19 and to diminish the danger 
of further worldwide spread by pronouncing the 
pandemic as Public Health Emergency of International 
Concern (PHEIC). 
In this review, the emergence, disease spectrum, 
modes of transmission, current status, and social 
impact of the SARS-CoV-2 infection on world map 
has been discussed. A plausible way to its prophylaxis 
and management through AYUSH systems of 
medicine has also been presented. This paper may be 
useful in better management of the current pandemic 
and its further escalation. 
Coronavirus disease 2019 (COVID-19) 
Causative agent & its origin 
There are 39 species of coronaviruses, coming 
under the family coronaviridae, suborder cornidovirineae 
and order nidovirales
2
. Most of the species are 
enzooticand only a small number of species can infect 
humans
3
. Currently, seven human CoVs (HCoVs) 
—————— 
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have been identified. Human coronaviruses are 
mainly linked with a range of mild to moderate upper 
respiratory tract disorders including common cold.  
Exact origin of the virus is still a mystery, to 
medical investigators around the world. However, it is 
believed that SARS-CoV-2 was introduced to humans 
by an intermediary animal species and then the 
human-to-human transmission was recorded. The 
WHO, on February 11, 2020, officially announced the 
viral disease as COVID-19
(refs 4,5)
. The coronavirus 
Study Group of the International Committee on 
Taxonomy of Viruses termed the new microbe as 
SARS-CoV-2
(ref. 6)
. The SARS-CoV-1 was detected in 
2002. During its course of transmission from 2002 to 
2003, a total of 774 deaths were recorded out of the 





The COVID-19 manifests gradually over an 
incubation period of around 14 days. During this time 
the virus multiplies in the upper and lower respiratory 
tract, forming lesions
8
. Researchers in China mentioned 
the average incubation period of 5.2 days
9
. The common 
symptoms of infection include high fever, dry cough, 
sneezing, fatigue, muscle pain, sore throat, diarrhea, 
anosmia, respiratory problems, etc. and some severe 
cases may have pneumonia, serious respiratory 
syndrome, kidney failure and even death
10,11
. Having 
these symptoms does not necessarily mean COVID-19, 
as similar symptoms can also be present in other viral 
infections. The chances of infection with COVID-19 are 
higher if there is shortness of breath, dry cough, and a 
person exposed to COVID-19 patient or traveled in a 
COVID-19 affected region. Elderly people, children, 
and the infected persons having health issues like 
pulmonary disorders, cardiac disorders, diabetes, and 
malignancies are at greater risk of catching the infection. 
However, some patients depending on their health status 
and age recuperate soon while others may take more 
time. Survival to death duration post infection is 6 to  
41 days with coronavirus. Age, health and co-morbid 
conditions of the patients play a major role in recovery
12
. 
The pathological findings of coronavirus include higher 
values of chemokines, cytokines, and leukocytes, and 






In the beginning cases of SARS-CoV-2 were 
linked to the Huanan seafood market of Wuhan, 
China and it was affirmed that the infection could 
have been spread through zoonotic or environmental 
exposures
9
. Further studies of the confirmed cases and 
detection of the root of the infection caused by SARS-
CoV-2 suggested human-to-human transmission 
leading to global pandemic
9
. The Coronavirus spreads 
either by direct contact or through the minute droplets 
released while coughing and sneezing. Usually, the 
virus enters the body through the nasal, oral route or 
through eyes
14
. It has been reported that a person can 
be infected at a distance of about 6 ft (1.8 m) radius. 
The virus can be active from 2 h to few days in the 
minute droplets released while coughing and 
sneezing, which can be on the surface or ground. 
Virus can be contacted by touching an object or 





 April 2020, as per WHO data it was 
reported that, the first case of this novel disease was 
detected in December 2019 and as of 9
th
 September 
2020 a total of 27,417,497 cases are reported to be 
infected by this virus globally which resulted in 
894,241 deaths
15
. In India, a total of 4,370,128 cases 
have been reported till now with death of 73,890 
individuals
15
. COVID-19 has shown its harsh effects 
among the America, Asia, Europe continents. Initially 
China and Italy were the hot spots but currently 
majority of cases and deaths are in USA, Brazil and 
India (Fig. 1). 
 
Impact of coronavirus 
The big negative impact of COVID-19 is due to the 
social distancing, which leads to anxiety and stress
16
. 
Anxiety and stress can disrupt and weaken the 
immune system and thereby an individual can easily 
catch COVID-19 infection
17,18
. Living a fast life with 
socializing has been diminished by lockdowns and 
social distancing. The unsocial public behavior is also 
observed to hoard essential food items and medical 
consumables during this pandemic. Black marketing 
of various medical consumables was also noticed due 
to their excess demand
13
. There were also reports of 
attack on healthcare workers, because of which 
Government of India had to pass a special bill for the 
protection of healthcare workers
19
. The next greatest 
misfortune is the financial loss which is around 2.7 
trillion USD
13
. COVID-19 has shown its brutal 
impacts on economy of each country. It has been 
predicted that COVID-19 may create serious 
problems like unemployment and destitution
20
. The 
position of financial backwardness will be more 








Environmental impact of this pandemic can be 
considered as a slight positive aspect of COVID-19. 
The restrictions on public movement and industries 
led to a significant improvement in air and water 
quality, leading to improvement in overall air quality 
index. Rivers and sea beaches were not polluted by 
human activities due to the nationwide lockdown
20
. 
There was significant reduction in emission of 
greenhouse gases in comparison to time after the 
World War II
20,21
. It has been reported that, in India 
the air quality was improved during first lockdown 
period of 21 days
21
. Because of quarantines and 





 in Wuhan and China, respectively 
[20]. PM 2.5 also fell by 1.4 μg/m
3
 in Wuhan  
and decreased by 18.9 μg/m
3
 in other 367 cities  
of China
20
. In India compared to previous year  
around 43, 31, 10, and 18% decrease in PM2.5, 
PM10, CO, and NO2, respectively, was observed  
this year during lockdown period
21
. 44, 33, 29, 15  
and 32% reduction in air quality index in north,  
south, east, central and western India respectively  
was noticed
21
. The noticeable reduction in the air, 
water, noise pollution and greenhouse gases are the 
good signs. 
The other positive side of COVID-19 is that all 
countries have learnt the importance of quality 
healthcare services and are trying their best to 
upgrade the same. Many nations have established 
better health infrastructure specially to cater the 
COVID-19 patients. Many companies adapted a new 
work culture called work from home during this 
pandemic which has curtailed traffic on the roads.  
Role of AYUSH systems of medicine to combat against 
COVID-19 
Management of epidemics is not new to traditional 
Indian health systems. Janapadodhwamsa vyadhi & 
Waba are well‑ defined terms used for epidemics in 
the classical Ayurvedic & Unani texts respectively. 
AYUSH systems of medicine which includes 
Ayurveda, Siddha, Unani, Yoga, Naturopathy and 
Homeopathy (AYUSH) becoming popular in general 
public. Drugs used in these systems are majorly from 
plants, minerals and animal origin. It is estimated that 
approximately 25,000 plant-based formulations are 




Management with Unani medicine 
Unani system of medicine is developed upon 
Hippocratic concepts of Mizaj (temperament) and 
Akhlat (humors)
23
. There is description of epidemic 
influenza in a book namely Al-asbab wa-Alamat (the 
book of causes and symptoms) written by 
Najeebuddin Samarqandi (d.1222 CE). This treatise 
has been translated in Urdu and published by the 
name Sharah Asbab in which this disease is 
delineated with the term Nazla-e-Wabaiya (epidemic 
influenza)
24
. Generally, the Unani medicines (plant-
based medicines) are considered to be safe without 
any side effects. Many plants are well known for 
their anti-viral activities
25-27
. Few of these medicinal 
plants are Allium cepa L., Allium sativum L., 
Cinnamomum verum J.Presl, Curcuma longa L., 
Daucus maritimus L., Glycyrrhiza glabra L., Piper 
nigrum L., Ocimum sanctum L., Ocimum tenuiflorum 
L., Zingiber officinale Roscoe etc. A decoction 
(joshanda) of these medicinal plants may be used for 
flu and common cold virus infections. Anti-viral 




Fig. 1 — Situation by WHO region as on 09th September, 2020 
 





. Certain drugs have been prescribed by Unani 
physicians that may be used in protecting the health 
during epidemics. Summary of these medicines is 




Management with Ayurveda 
Ayurveda is a very esteemed and primeval 
traditional system of medicine that has been practiced 
since antiquity in India. It offers both preventive and 
therapeutic treatment for number of ailments. Mild to 
moderate symptoms of the patient infected with 
COVID-19 can be managed with Ayurveda
56,57
. Some 




 Consumption of luke-warm water is advocated 
which is known to have body cleansing effects. 
 Consume diet which substantially contains 
Lehsun, Haldi and Zeera for promotion of health. 
 Ayurvedic immune-boosters (chyawanprash) may 
be used which rejuvenates the body. 
 Turmeric dissolved in milk is commonly used 
especially for its anti-inflammatory effects and 
considered as healthy drink. 
 Consume sesame or coconut oil or ghee which 
has coolant properties and help in healing. 
 Use of powder of Laung (Syzygium aromaticum) 
(L.) Merr. & L.M. Perry in combination with 
brown sugar or honey is prevalent in throat 
infection. 
 Inhalation of Kapoor (Cinnamomum camphora) 
(L.) J. Presl. directly or local application in the 
form of balm or ointment, also has positive effect 
in respiratory disease. 
 
Management with Homoeopathy 
Arsenic when given in ultra diluted form, as used 
in Homoeopathy, has been found beneficial for 
several diseases including viral infections. Arsenic 
trioxide is highly diluted to obtain Arsenicum Album-
30 which has been widely used in epidemics for flu 
like symptoms as a prophylactic medicine. For 
COVID-19, the dose recommended is one dose of 
Arsenicum Album 30 daily on empty stomach for  
3 consecutive days to be repeated after one month in 
the same manner if the infection still remains in the 
population. It is also pertinent to mention that in a 
Table 1 — Health protective drugs used in Unani medicine 
S. No. Botanical name Unani name Part used Method of use in 
Unani medicine 
Mode of action/rationale 
for use 
References 
1. Acetic acid (vinegar) Sirka Whole Spray Anitmicrobial, antioxidant, 
antiobesity 
41,42 
2. Alhagi pseudalhagi  
(M. Bieb.) Desv. ex B. 














4. Crocus sativus L. Zafran Stamen Oral Immunoregulatory, anti-
inflammatory 
44,46 










7. Punica granatum L. Anar Fruit juice Oral Anitmicrobial, antioxidant, 
antifungal, anti-viral 
44,49 
8. Rheum australe D. Revand 
Chini 
Rhizome Oral Anitmicrobial, antioxidant, 
anti-inflammatory 
44,50 
9. Rhus coriaria L. Sumaq Fruit Gargle Antibacterial against oral 
bacteria 
42,51 
10. Rosa damascena Herrm. Arq-e-Gulab Distillate of 
petals 
Gargle Antioxidant; contains 
alcohols 
42,52 
11. Tamarindus indica L. Imli Pulp Oral Analgesic, anti-
inflammatory 
44,53 
12. Terminalia chebula 
Retz. 
Halela Fruit Oral Antibacterial 44,54 
13. Viola odorata L. Banafsha Flowers Oral Anitmicrobial, antifungal 44,55 




study of Arsenicum album, it was found to be 
effective in swine flu patients with symptoms like 
fever, runny nose, headache, sore throat
58
. Other 
medicines that are being prescribed in the 
management of COVID-19 are Atropa belladonna, 
Bignonia sempervirens, Bryonia alba, Eupatorium 




Management with Yoga and Naturopathy 
Yoga and Naturopathy are the drugless systems of 
medicine based on preventive and adjuvant care which 
can be integrated with other proposed interventions, 
and thereby helping the body towards achieving health 
and well-being. Yoga and Naturopathy are guided by 
ancient Indian science of health and wellbeing with 
scientific developments that upholds the body's natural 
ability to heal itself, improves disease prevention, and 
enhances ones capability to achieve optimal health. 
Studies have shown that mental stress is linked with 





 which shows that stress causes 
significant immune response dysfunction. There  
are evidences which points at the role of Yoga in 
establishing homeostasis in association with the 
nervous, endocrine, and immune systems
62
. Therefore, 
it can be said that lifestyle modification based on  
Yoga and Naturopathy interventions, integrated  
with standard care can help in promoting physical as  





Management with Siddha 
Siddha system of medicine has existed from the 
time immemorial. In Siddha system main concept is 
“Unava Marunthu, Marunthae Unavu” which means 
food is medicine, medicine is food. In Siddha system 
of medicine infectious disease are called “Thotrunoikal, 
kollainoikal, ottunoikal
65
. Kabasura kudineer is a 
poly-herbal formulation consists of fifteen drugs 
prescribed for the preventive and symptomatic 
treatment of COVID -19 patients
66
. The preparations 
like thalisathi chooranam and adathodai manapagu 
are also used as prophylactic drug against COVID-
19
66
. Immune boosters like nelikai legiyum, senthil 
sarkari, amukuura choorna mathirai, brahamanantha 




Recommended AYUSH medicines for prevention and 
symptomatic management of COVID-19 
Government of India through AYUSH  
Ministry issued an advisory. The advisory advocates 
prophylactic and symptomatic management  
of COVID-19 and outline some AYUSH medicines. 
These medicines are mentioned in Table 2 but they 




Table 2 — AYUSH medicines for prevention and management of COVID-19
(ref. 5)
 
Drug Form System Administration Reported activities 






Aqueous Ayurveda Twice a day for 









Aqueous Siddha 60 ml decoction, twice a 
day for 14 days 




Zizyphus jujube Mill. 
(Unnab) 
Cordia myxa L. 
(Sapistan) 
Aqueous Unani Boil Cydonia oblonga Mill. 
(3 part), 
Zizyphus jujube Mill.  
(5 parts), and 
Cordia myxa L. (9 parts) in 
250 mlwater and reduce to 
half. Use decoction twice a 






Arsenicum album 30 Globules Homoeopathy Daily once in a day on empty 
stomach for 3 days (Should 
be repeated after 1 month till 
the infection persist) 
Effective  in epidemics, 
immune-modulator 
(Contd.) 




Table 2 — AYUSH medicines for prevention and management of COVID-19ref 5 
Drug Form System Administration Reported activities 









Ayurveda Two tablets twice day 
 




2 drops in each nostril 
daily morning 













Kaba sura kudineer 
Siddha 10 ml twice a day 
 
60 ml decoction, twice 
a day 
 
60 ml decoction, twice 
a day 
 Fever and cold 
 
 




Fever, cough, sore throat, 
shortness of breath 












Homoeopathy As prescribed by 
physician 














Human civilization has been very harshly affected 
by COVID-19. As of now no confirmed cure exist for 
this disease. Due to unavailability of vaccine against 
COVID-19, disease is currently managed symptomatically 
with varied anti-viral drugs. Therefore, it demands  
to take actions for awareness raising campaign, 
harmony, and joint efforts among various medical 
systems and healthcare institutions. Therefore, to 
counter the pandemic, an integrated process is needed 
wherein AYUSH systems of medicine can contribute 
extensively. The AYUSH inputs advocates strengthening 
general immunity so that a larger proportion of the 
number of exposed are able to remain asymptomatic 
or experience only mild disease, and fewer proportions 
move to become severe cases. Research to evaluate 
and establish role of potent herbs as prophylactic 
agent against viral infections can also be planned.  
It is also suggested and appealed that general  
public should strictly observe norms and guidelines  
of prevention, social distancing and quarantine,  
issued by Government from time to time. A  
mechanism should also be developed for educating 
younger generation to withstand against any  
such catastrophe in future. Briefly, collective efforts  
are required globally to fight against such diseases in 
future. 
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